Navigation Links
Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications
Date:3/31/2009

MOUNTAIN VIEW, Calif., March 31 /PRNewswire/ -- Based on its recent analysis of the optical technologies market, Frost & Sullivan recognizes Carl Zeiss Meditec with the 2009 North American Frost & Sullivan Market Leadership Award for its optical coherence tomography (OCT) technology for ophthalmic applications. Carl Zeiss Meditec is a pioneer of OCT technology and has launched clinical tools that revolutionized the diagnosis and treatment of eye diseases.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Carl Zeiss Meditec was the first to introduce Time Domain (TD) OCT-based innovative products for retinal, anterior segment/cornea, and glaucoma imaging. More recently, the company introduced the next generation of Fourier Domain (FD) OCT-based product line for ophthalmic applications.

"Multiple start-up companies have introduced promising FD OCT-based products, creating an increasingly competitive dynamic," says Frost & Sullivan Senior Research Analyst Madhu Sharma, Ph.D. "Nonetheless, Carl Zeiss Meditec has responded by implementing an innovation-centric strategy focused on continually presenting novel products and thereby, maintaining a dominant market position."

The company's OCT systems are one of the most widely adopted clinical tools among ophthalmologists. The Stratus OCT(TM) and new Cirrus(TM) HD-OCT systems offer proficiencies and streamlined workflows that allow physicians to gather and interpret detailed disease information.

Additionally, the company has developed proprietary image analysis algorithms that provide volumetric data and aid in interpreting three dimensional images in a highly reproducible and quantitative fashion. It continues to invest in upgrading software for objective measurement and subjective clinical evaluation of retinal disease detection. T
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Frost & Sullivan Hosts Presentation on MicroRNAs: From Stem Cells and Cancer to Diagnostics and Therapeutics
2. Frost & Sullivan Award Highlights Opportunity for Main Street Biotech
3. Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry
4. Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
5. Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
6. Frost & Sullivan: In Vitro Diagnostics Market
7. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
8. Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG
9. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
10. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
11. Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Dyadic International, Inc. (Pink Sheets: ... its collaboration with The Scripps Research Institute ("Scripps") ... re-annotate the genome of Dyadic,s patented and proprietary ... continuation of the successful relationship between the two ... engaged Scripps to annotate the C1 genome for ...
(Date:12/14/2009)... NATICK, Mass., Dec. 14 Boston Scientific Corporation ... of a public offering of $2 billion aggregate principal ... registration statement. The public offering consists of $850 ... million of 6.00 percent notes due January 2020 and ... Boston Scientific plans to use the net proceeds ...
(Date:12/14/2009)... Dec. 14 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, owing to ... fibrillation drug market will increase more than sevenfold ... in 2018 in the United States, France, Germany, ... The new Pharmacor report entitled Atrial Fibrillation ...
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), today announced ... from sales of Thalomid® during the third quarter ... In addition, the Company anticipates a decrease ... 2009. The difference in estimated and actual ... in the fourth quarter financial results. ,, (Logo: ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2
... ZMH ; SWX: ZMH) announced that certain of ... from Abbott for approximately,$360 million in cash. Zimmer said ... hand and borrowings under existing credit facilities., The ... of 2008. The,boards of directors of both companies have ...
... Colo., Sept. 4 InVitria,( http://www.invitria.com ... animal free,products that enhance productivity, safety ... the biopharmaceutical, cell culture, life science ... of Cambridge Healthtech,Institute,s 4th Annual "Optimizing ...
... and National Development in Taiwan, 1950-2000, Celebrates ... Editor of a Comprehensive History of ... Dialogue on a National Health Care System ... Worth Studying, NEW YORK, Sept. 4 ...
Other Biology Technology:Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 2Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 3Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 4InVitria Sponsors Cambridge Healthtech's Optimizing Cell Culture Development Conference 2ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan 2ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan 3
(Date:12/11/2009)... in French . , Montreal, December ... molecular mechanism that prevents cancer. In the December 11 ... scientists from the Universit de Montral and the Universit ... molecule prevents the cancer-causing activity of cytokines, hormones that ... Crohns, in smokers and people exposed to asbestos. ...
(Date:12/11/2009)... growers, profits have traditionally been limited by ... growing seasons can be short. Thanks to ... are being introduced that offer growers the ... in economic bonuses for both producers and ... of blackberry called "primocane-fruiting", which bear fruit ...
(Date:12/11/2009)... best dietary source of Omega 3, according to a study ... The scientists analysed the eggs, or roe, of 15 marine ... these fatty acids, which are essential to the human body. ... the nutritional potential of the roe of marine animals, but ... that this is one of the best natural sources of ...
Breaking Biology News(10 mins):Scientists identify natural anti-cancer defenses 2New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2CIGNA Corp s John M Murabito Named 2009 HR Executive of the Year 58750 1CIGNA Corp s John M Murabito Named 2009 HR Executive of the Year 58750 2CIGNA Corp s John M Murabito Named 2009 HR Executive of the Year 58750 3CIGNA Corp s John M Murabito Named 2009 HR Executive of the Year 58750 4R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 1R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 2R 26amp 3BD Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 58745 3New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 1New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 2New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 3New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 4New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 5New Fall Allergy Capitals 28TM 29 Reveal the Most Challenging Cities for Allergy Sufferers 5186 6
... Acid rain was one of the worlds worst pollution problems ... Britain, as well as Europe and North America. , In ... been acidified, harming fish, stream insects and river birds such ... has been taken across Europe to clean up acid pollutants ...
... States participating in the GMES Programme approved the transition ... Component Programme. , Oversubscription of the programme by the ... with oversubscription to phase 2 of 116%, giving a ... the programme will allow ESA to confirm the development ...
... the United States is a neurological event such as ... cause, the brain is often quickly and irreversibly damaged. ... the National Institutes of Health, will study point-of-care technologies ... neurologic emergencies. The result is the "Point-of-Care Center for ...
Other Biology News:Recovery from acid rain 'much slower than expected' 2NIH awards UC $9 million grant to improve patient point-of-care technologies 2NIH awards UC $9 million grant to improve patient point-of-care technologies 3
The Magnetic Separation Rack is designed to be used for small-scale separations using magnetic particles. ,Capacity: 6 microcentrifuge tubes....
... the 9, 10, 12, and 13 positions. It ... for the quantification of 9(S)-HODE by GC- or ... of linoleic acid in both plants and animals. ... an esterified component of membrane phospholipids and in ...
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
...
Biology Products: